Trinity Biotech (TRIB) Total Liabilities (2009 - 2025)

Trinity Biotech has disclosed Total Liabilities across 17 years of filings, most recently posting $177.1 million for Q4 2025.

• Total Liabilities for Q4 2025 came in at $177.1 million, up 27.93% year-over-year; the trailing twelve-month figure through Dec 2025 was $177.1 million (up 27.93% YoY), and the FY2025 annual result was $177.1 million, up 27.93% from the prior year.
• Total Liabilities came in at $177.1 million for Q4 2025 at Trinity Biotech, up from $149.2 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $177.1 million in Q4 2025 to a low of $81.1 million in Q3 2023.
• The 5-year median for Total Liabilities is $116.2 million (2021), against an average of $114.6 million.
• Across the five-year window, Total Liabilities slipped 27.07% in 2022 and surged 66.06% in 2024, its largest moves.
• Trinity Biotech's Total Liabilities stood at $119.2 million in 2021, then dropped by 20.92% to $94.3 million in 2022, then fell by 11.56% to $83.4 million in 2023, then soared by 66.06% to $138.5 million in 2024, then increased by 27.93% to $177.1 million in 2025.
• The last three Total Liabilities figures came in at $177.1 million (Q4 2025), $149.2 million (Q2 2025), and $138.5 million (Q4 2024), per Business Quant data.